Denosumab (Prolia) Hypocalcemia Lawsuit Lawyers

As one of the nation’s premier personal injury and mass tort law firms, we are capable of successfully handling all types of cases. If you or a loved one are injured due to the negligence of another, there is no better place to help advocate for your rights than Parker Waichman LLP.

Denosumab (Prolia) Hypocalcemia Lawsuit Lawyers

FDA Issues Boxed Warning for Osteoporosis Drug Denosumab (Prolia)

Denosumab Hypocalcemia Lawsuits
Denosumab Hypocalcemia Lawsuits

 

In a recent development, the Food and Drug Administration (FDA) has taken a significant step by adding a boxed warning to the label of the osteoporosis drug denosumab, commonly known as Prolia. This warning specifically addresses the potential risk of severe hypocalcemia in patients with advanced chronic kidney disease (CKD), as announced by the agency on a recent Friday.

The decision to implement this boxed warning follows a comprehensive review of available evidence, including fresh data published in the Journal of the American Medical Association (JAMA). Based on their analysis, the FDA has concluded that denosumab carries an increased risk of severe hypocalcemia, particularly when compared to bisphosphonates, in patients with advanced CKD, particularly those undergoing dialysis. It is important to note that patients on dialysis or suffering from mineral and bone disorder (MBD) are at the highest risk of experiencing significantly low blood calcium levels.

The newly acquired data, primarily involving women undergoing dialysis, revealed alarming statistics. Approximately 41% of patients developed severe hypocalcemia within the initial 12 weeks of denosumab treatment, in stark contrast to only 2.0% of those who were prescribed oral bisphosphonates.

The boxed warning, described by the FDA as the “most prominent” warning, serves as a cautionary notice about the potential for severe harm arising from severe hypocalcemia. This harm could manifest as hospitalization, life-threatening events, and even fatalities among patients with advanced CKD who are using denosumab. Symptoms of severe hypocalcemia may vary from being asymptomatic to presenting with confusion, seizures, irregular heart rhythms, fainting, facial twitches, uncontrolled muscle spasms, or sensations of weakness, tingling, or numbness in specific body areas.

As part of their latest communication on drug safety, the FDA has advised healthcare professionals to exercise utmost caution in selecting appropriate candidates for denosumab treatment. Furthermore, they recommend intensified monitoring of blood calcium levels, especially during the initial 2 to 10 weeks following each injection. In some cases, patients may also require calcium and vitamin D supplements to manage their condition effectively.

Before prescribing denosumab, healthcare providers are strongly encouraged to assess their patients’ kidney function and carefully consider the risk of severe hypocalcemia in the context of other available osteoporosis treatment options for patients with advanced CKD, particularly those undergoing dialysis.

The FDA underscores the importance of patients not discontinuing their denosumab medication without first consulting their healthcare provider. Abruptly ceasing treatment may have adverse consequences, and patients are advised to seek professional guidance in this matter.

This label update by the FDA follows an initial safety alert issued in November 2022, which highlighted the potential risk of hypocalcemia associated with denosumab in women dependent on dialysis. The alert was prompted by interim findings from Amgen, the manufacturer of denosumab, as part of an ongoing safety study that indicated an elevated risk of hypocalcemia in patients with advanced kidney disease.

Originally approved in 2010 for postmenopausal women at high risk of bone fracture due to osteoporosis, denosumab has expanded its indications over time. It is now used to treat osteoporosis in men, glucocorticoid-induced osteoporosis, bone loss in patients receiving androgen-deprivation therapy for prostate cancer, and in women undergoing aromatase inhibitor therapy for breast cancer. Additionally, it is approved under the trade name Xgeva to reduce the risk of bone-related events in specific cancer patients.

Administered via injection every six months, denosumab functions by inhibiting the protein receptor activator of nuclear factor kappa beta (RANK), thereby preventing the breakdown of bone by osteoclasts in the body.

The FDA encourages both patients and healthcare professionals to promptly report any side effects related to denosumab to their MedWatch program, ensuring that concerns are addressed and safety is prioritized.

Filing Your Denosumab Hypocalcemia Lawsuit

If you or a loved one have experienced adverse effects or harm from denosumab (Prolia), it is crucial to seek legal guidance to understand your rights and options. Victims of such pharmaceutical issues may have grounds for legal action to seek compensation for their injuries. Product liability lawsuits can hold manufacturers accountable for producing and distributing defective drugs that cause harm to consumers.

The process of pursuing a product liability lawsuit is intricate and often necessitates the expertise of an attorney at each stage to ensure a favorable outcome. Here is an overview of the steps involved and the reasons why legal representation is crucial:

  1. Consultation: Victims should initiate a consultation with an attorney specializing in product liability cases. During this initial meeting, the attorney will evaluate the merits of the case and provide insights into the best course of action.
  2. Investigation: Attorneys will conduct a thorough investigation to gather evidence establishing the drug’s defect, its link to the injuries sustained, and the extent of damages suffered by the victim.
  3. Filing the Lawsuit: Once sufficient evidence is gathered, the attorney will file a product liability lawsuit against the drug manufacturer, in this instance, the maker of denosumab.
  4. Discovery: The discovery phase involves exchanging information between both parties. The manufacturer’s defense team will present their evidence, while the victim’s attorney continues to build their case.
  5. Negotiation or Trial: In some instances, negotiations may take place to reach a settlement. If an agreement cannot be reached, the case proceeds to trial, where a judge or jury determines liability and potential damages.
  6. Damages: In the event of a successful lawsuit, victims may be entitled to various forms of compensation, including medical expenses, lost income, pain and suffering, and punitive damages.

Legal representation is paramount at each step of this complex process, as attorneys possess the necessary expertise to navigate legal intricacies, advocate for the victim’s rights, and ensure they receive fair compensation for their suffering.

The FDA’s decision to issue a boxed warning for denosumab (Prolia) underscores the gravity of the situation and the potential harm this drug can cause. Victims of such pharmaceutical issues have legal avenues to seek compensation for their injuries, and seeking the counsel of an experienced attorney is vital to navigating the complexities of a product liability lawsuit. Take proactive steps to address your concerns, and reach out to trusted law firms like Parker Waichman LLP to ensure your rights are safeguarded.

Parker Waichman LLP is a nationally acclaimed personal injury law firm committed to safeguarding the rights of those who have suffered due to the negligence of others. Our nationwide law firm has earned a distinguished reputation, founded on our unwavering dedication to securing justice and delivering award-winning advocacy on behalf of our clients throughout the United States. Our law practice is exclusively focused on personal injury law, and we are unyielding in our pursuit of just monetary compensation for the suffering our clients have endured.

CONTACT PARKER WAICHMAN LLP FOR A FREE CASE REVIEW

If you or someone you know has been affected by the risks associated with denosumab (Prolia), we encourage you to take action by contacting a reputable national product injury law firm such as Parker Waichman LLP. They offer free consultations to victims who call 1-800-YOUR-LAWYER (1-800-968-7529). Don’t hesitate to seek professional guidance and protect your rights in the pursuit of justice and compensation for your injuries.

Regardless of your location or where your injury occurred, our nationwide personal injury law firm is ready to assist you.

Free Consultation
Parker Waichman LLP
Are you inquiring about a new matter?
What type of accident did you have?
Please share a few details about your inquiry so we can connect you with the best person to assist you.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
4.8 from 549 Reviews

Client Reviews

Our law firm is ready to represent you in your injury case. We’ve helped many New York residents as well as those needing help nationwide. Contact our team for a free case consultation today.

I thank you so much Benita Rollis. for always contact me and given me updates, you always returned my calls and process my documents, informing me about the documents I needed to make things move faster. you was very professional and always courtesy and kind to me. Thank you Luis F
Luis Franceschi
2 years ago
It is still early in the process for me and I have been kept abreast of matters effecting my case by Jillian, my case manager and Cathy, my paralegal. One aspect of the firm that I had not anticipated was the care and concern shown for my well being by Joanne, the nurse. PARKER WAICHMAN LLC is my law firm and I am glad I contacted them to work on my case. Update: Denny Tang, Esq., handled my case with updates to me throughout the process. He appears genuinely caring about his clients and that quality is priceless. Jillian Cantinieri, Legal Secretary, was initially my go to contact at the firm and performed her duties in a stellar manner. She is an exemplary employee and I am very pleased Jill was assigned to my case.
Jacqueline Kowitz
4 years ago
Engaged PW after my mother's untimely passing in 2018. Sought help with other firms who declined but PW felt strongly we had a case. Although hampered by the court delays of the Pandemic and the horrible and ongoing, wretched behavior of the defendants, PW endured to eventual success. I credit many along the way but especially Michele Josama who was one of the very first people I met in the journey. She and the others helped me through a very difficult and emotionally trying period against an awful nursing home group. They believed we would persevere and we did! PW professionals are knowledgeable, tough and compassionate. You pushed it over the line, Craig Snyder, thanks! And MANY THANKS TO ALL OF YOU!! I would not hesitate in engaging this qualified firm again.
Bruce Bennett
8 months ago
I don't feel that I could have asked for a more better professional legal working team to have represented every aspects of my legal case and to have also had the opportunity to get to see what all this entails and so their cases are of sussessful ones. Thank you for all of those at Parker and Waichman!
Diana Larsen
3 weeks ago

Contact Us Today

If you or a loved one has been injured in an accident or have been injured by another party in some other way, we are here to stand up for your rights. Our personal injury attorneys have been representing injury victims and their families in Long Island and throughout the nation since the early 1980s.